Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The effect of vitamin D3 and omega-3 Fatty acids on estradiol levels.
The data about effect of vitamin D3 (VD3) and omega-3 fatty acids (omega-3FA) on serum levels of estradiol (E2) are scarce and conflicting and nothing is published in the literature about the effect of the combination of VD3 and omega-3FA on the E2 levels.
This study was conducted to investigate effect of VD3 and omega-3FA alone and with each other on serum E2 levels in premenopausal females with vitamin D deficiency (VDD).
This randomized, placebo-controlled clinical trial was designed to test effects of 50,000 IU VD3 weekly and 300 mg omega-3FA daily for eight weeks, separately and with each other, on the mid-follicular serum levels of E2 and 25-hydroxy vitamin D (25OHD). This study was conducted during winter in 86 healthy premenopausal Jordanian females with VDD with a mean age of (32.8 ± 8.9) years. Fasting serum levels for 25OHD, E2, PTH (parathyroid hormon), calcium, phosphate, ALT (alanine aminotransferase), and urea were assessed at baseline and the end of the trial.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| VD3 group | Experimental | treated with 50,000 IU VD3 / week |
|
| omega3-FA group | Experimental | 1000 mg wild salmon and fish oil complex (contains 300 mg of omega3-FA) once daily |
|
| VD3 and Omega-3FA group | Experimental | 50,000 IU VD3 / week and 1000 mg wild salmon and fish oil complex (contains 300 mg of omega-3FA) once daily |
|
| Control group | Other | No intervention was given |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| VD3 | Dietary Supplement | 50,000 IU VD3 / week for 8 weeks |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma concentrations of 25-hydroxyvitamin D, estradiol | Concentration | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma concentrations of PTH, Ca | Concentration | 8 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Premenopausal females
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mahmoud S Abu-Samak, PhD | Applied Science Private University | Principal Investigator |
Not provided
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 18400738 | Background | Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008 Apr;87(4):1080S-6S. doi: 10.1093/ajcn/87.4.1080S. | |
| 30787641 | Derived | Al-Shaer AH, Abu-Samak MS, Hasoun LZ, Mohammad BA, Basheti IA. Assessing the effect of omega-3 fatty acid combined with vitamin D3 versus vitamin D3 alone on estradiol levels: a randomized, placebo-controlled trial in females with vitamin D deficiency. Clin Pharmacol. 2019 Feb 4;11:25-37. doi: 10.2147/CPAA.S182927. eCollection 2019. |
Not provided
Not provided
all IPD that underlie results in a publication
when summary data are published
open access
Not provided
Not provided
| ID | Term |
|---|---|
| D014808 | Vitamin D Deficiency |
| ID | Term |
|---|---|
| D001361 | Avitaminosis |
| D003677 | Deficiency Diseases |
| D044342 | Malnutrition |
| D009748 | Nutrition Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Omega3-FA |
| Dietary Supplement |
300 mg of omega3-FA once daily for 8 weeks |
|
| VD3 and Omega-3FA | Dietary Supplement | 50,000 IU VD3 / week for 8 weeks and 300 mg of omega-3FA once daily for 8 weeks |
|
| Control | Other | No intervention was given |
|
| D009750 |
| Nutritional and Metabolic Diseases |